<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-63345</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Introduction and objectives. Tumor necrosis factor-alpha (TNF-alpha) is implicated in a variety of inflammatory processes, including cardiovascular disease. Little is known about the prognostic value of TNF-alpha in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to determine the prognostic value of TNF-alpha in this clinical setting at six-month follow-up. Methods. The levels of TNF-alpha, C-reactive protein (CRP), interleukin 6 and type 1 soluble intercellular adhesion molecules measured within the first 10 h of symptom onset and at 48 h in 74 consecutive patients admitted with STEMI. The relationships between these levels and the incidence of ischemic events (i.e., angina, reinfarction, and death), heart failure (HF), or both (i.e., all cardiovascular events) were studied. Results. Overall, TNF-alpha levels were significantly higher in patients who had an ischemic event or HF than in those who did not (P&lt;.02 for both). At 48 h, the adjusted odds ratios of those in the highest TNF-alpha quartile (2.92 pg/mL) for the development of ischemic events, HF, and all cardiovascular events combined were 13.1, 9.59 and 9.75, respectively. A TNF-alpha level of 2.04 pg/mL at 48 h had a sensitivity of 78% and a specificity of 72.5% in predicting a cardiovascular event of any form. The CRP level, but not the TNF-alpha level, at admission was found to be an independent predictor of the development of a cardiovascular events. Conclusions. In patients with STEMI, the plasma TNF-alpha level 48 h after symptom onset and the CRP level at admission were independent predictors of cardiovascular events (AU)</dc:description>
<dc:creator>Cubero, Tomás</dc:creator>
<dc:creator>Carnero, Andrés</dc:creator>
<dc:creator>Pérez-Paredes, Matías</dc:creator>
<dc:creator>Martínez-Corbalán, Francisco</dc:creator>
<dc:creator>Ureña, Isabel</dc:creator>
<dc:creator>Carrillo, Andrés</dc:creator>
<dc:creator>Lozano, María L</dc:creator>
<dc:creator>García-Almagro, Francisco J</dc:creator>
<dc:creator>Giménez, Diego M</dc:creator>
<dc:creator>Gonzálvez, Juan J</dc:creator>
<dc:creator>Gonzálvez, Manuel</dc:creator>
<dc:creator>Vicente, Vicente</dc:creator>
<dc:creator>Ruiz-Ros, José A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. Entre la variedad de procesos inflamatorios que implican al factor de necrosis tumoral alfa (TNF&amp;#945;), se encuentra la enfermedad cardiovascular. Su valor pronóstico en el infarto agudo de miocardio con elevación del segmento ST (IAMEST) es poco conocido. Este estudio trata de determinar el valor pronóstico del TNF&amp;#945; en este marco clínico tras 6 meses de seguimiento. Métodos. Se midieron las concentraciones de TNF&amp;#945;, proteína C-reactiva (PCR), interleucina 6 y moléculas solubles de adhesión celular tipo 1 en las primeras 10 h tras el inicio de los síntomas y tras 48 h en 74 pacientes con IAMEST. Se correlacionaron sus valores con la incidencia de eventos isquémicos (angina, reinfarto y muerte), insuficiencia cardiaca o ambos (eventos cardiovasculares). Resultados. Los valores de TNF&amp;#945; fueron significativamente mayores en pacientes con eventos isquémicos o insuficiencia cardiaca que en aquellos sin eventos (p &lt; 0,02 para todos). A las 48 h, las odds ratio (OR) ajustadas para el último cuartil de TNF&amp;#945; (2,92 pg/ml) eran OR = 13,1; OR = 9,59 y OR = 9,75 para el desarrollo de eventos isquémicos, insuficiencia cardiaca y eventos cardiovasculares combinados, respectivamente. La concentración de TNF&amp;#945; a las 48 h de 2,04 pg/ml tuvo una sensibilidad del 78% y una especificidad del 72,5% en la predicción conjunta de dichos eventos. Al ingreso, la PCR, pero no el TNF&amp;#945;, mostró valor predictivo independiente en el desarrollo de eventos cardiovasculares. Conclusiones. En pacientes con IAMEST, la concentración plasmática de TNF&amp;#945; a las 48 h y la PCR al ingreso son predictores independientes de eventos cardiovasculares (AU)</dc:description>
<dc:source>Rev Esp Cardiol;60(12): 1233-1241, dic. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-63345</dc:identifier>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d22124^s22002</dc:subject>
<dc:subject>^d9395^s22032</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d32174^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7426^s22032</dc:subject>
<dc:subject>^d29591^s22063</dc:subject>
<dc:subject>^d29472^s22002</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:type>article</dc:type>
<dc:date>200712</dc:date>
</metadata>
</record>
</ibecs-document>
